← Leaderboards
Herbert K Proudfit
University Of Iowa
$1,305,093
Attributed
$1,305,093
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $147.5K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$1,305,093 · 2
By mechanism
R01$1,013,559 · 1
R21$291,534 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Kathleen A Sluka$22,348,650
- Donna L Hammond$13,412,619
- Timothy John Brennan$5,118,000
- Gerald F Gebhart$14,892,742
- Yuriy M Usachev$12,753,522
Others in their field
Top investigators on “Analgesia”
- Maurizio Fava · Massachusetts General Hospital$19,316,294
- Jeffrey Reich · Sparian Biosciences, Inc.$17,713,936
- Ying-Xian Pan · Sloan-Kettering Institute For Cancer Res$15,750,064
- Gavril W Pasternak · Sloan-Kettering Institute For Cancer Res$12,931,641
- James C Eisenach · Wake Forest University$12,609,414
- James N Weinstein · Dartmouth College$12,589,103
Research focus
AnalgesiaBrain StemCatecholaminesCell TypeCentral Nervous SystemChemical StimulationDorsal HornElectrophysiologyElectrostimulusEnkephalinsGamma AminobutyrateImmunocytochemistryInhibitor /AntagonistLaboratory RatMedulla OblongataNeural Information ProcessingNeuroanatomyNeurochemistryNeuronsNeuropharmacologyNorepinephrinePeriaqueductal Gray MatterSpinal CordSubstance P
Grant awards (6)
Dendritic Varicosities Regulate Neuronal Excitability$144,034
R21 · FY2006 · DA · contact PI
Dendritic Varicosities Regulate Neuronal Excitability$147,500
R21 · FY2005 · DA
PHARMACOLOGIC STUDIES OF CNS PAIN MOLULATORY SYSTEMS$264,256
R01 · FY2003 · DA
PHARMACOLOGIC STUDIES OF CNS PAIN MOLULATORY SYSTEMS$258,388
R01 · FY2002 · DA
PHARMACOLOGIC STUDIES OF CNS PAIN MOLULATORY SYSTEMS$249,084
R01 · FY2001 · DA
PHARMACOLOGIC STUDIES OF CNS PAIN MOLULATORY SYSTEMS$241,831
R01 · FY2000 · DA